MONOPHARMA Quarterly Results, Profit & Loss, Balance Sheet (MONOPHARMA) MONOPHARMA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Mono Pharmacare Ltd (MONOPHARMA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Mono Pharmacare Ltd reported sales of ₹99 Cr, operating profit of ₹2 Cr (OPM 2.2%) and net profit of ₹0 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.
MONOPHARMA quarterly results (₹ Cr) Metric Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026 Sales 35 67 56 87 81 66 99 Expenses 33 63 53 82 78 65 97 Operating Profit 2 4 2 5 3 2 2 OPM 6% 6% 4.4% 5% 3.6% 2.7% 2.2% Other Income 0 0 0 0 1 0 0 Interest 1 2 2 2 2 2 2 Depreciation 0 0 0 0 0 0 0 Profit before tax 1 2 1 3 1 0 0 Tax 39% 20% 33% 27% 37% 83% 29% Net Profit 1 2 1 2 1 0 0 EPS in Rs 0.52 1.06 0.33 1.3 0.46 0.01 0.19
MONOPHARMA profit & loss, annual (₹ Cr) Metric Mar 2023 Mar 20236m Mar 2024 Mar 2025 Mar 2026 TTM Sales - 33 122 168 166 147 Expenses - 31 116 161 162 143 Operating Profit - 2 6 8 4 5 OPM - 7% 5% 4.5% 2.4% 3% Other Income - 0 0 1 0 1 Interest - 1 3 4 3 4 Depreciation - 0 0 0 0 0 Profit before tax - 1 3 4 1 1 Tax - 29% 24% 30% 40% - Net Profit - 1 2 3 0 1 EPS in Rs - 0.76 1.38 1.75 0.2 0.47 Dividend Payout - 0% 0% 0% 0% -
MONOPHARMA balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 12 18 18 18 18 Reserves 1 10 14 14 14 Borrowings 40 41 54 55 56 Other Liabilities 9 12 25 33 34 Total Liabilities 63 81 110 119 122 Fixed Assets 1 1 1 1 1 CWIP 0 0 0 0 0 Investments 1 0 0 0 0 Other Assets 61 80 109 118 121 Total Assets 63 81 110 119 122
MONOPHARMA cash flows (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity -40 -9 -4 2 Cash from Investing Activity -1 0 0 0 Cash from Financing Activity 41 8 5 -2 Net Cash Flow 0 0 0 0 Free Cash Flow -40 -9 -5 2 CFO/OP -1,765% -126% -38% 64%
MONOPHARMA ratios Metric Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 241 94 91 165 Inventory Days 408 139 133 99 Days Payable 87 32 45 68 Cash Conversion Cycle 563 202 179 196 Working Capital Days 299 131 120 126 ROCE - 10% 11% 5%